Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2004
03/10/2004EP1395582A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
03/10/2004EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins
03/10/2004EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists
03/10/2004EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production
03/10/2004EP1395538A1 Vitamin d analogues
03/10/2004EP1395286A2 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist
03/10/2004EP1395285A2 Reagents and methods for modulating dkk-mediated interactions
03/10/2004EP1395277A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
03/10/2004EP1395269A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
03/10/2004EP1395238A1 Skin preparation
03/10/2004EP1395231A1 Preparation for the removal of abnormal keratin material
03/10/2004EP1303249B1 Antimycotic nail varnish composition
03/10/2004CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa
03/10/2004CN1481373A 1,5-benzothiazepines compounds and its use as antilipemic agent
03/10/2004CN1481370A Quinazoline derivatives, medicaments contg. said compounds, their utilization and method for prodn. thereof
03/10/2004CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof
03/10/2004CN1481366A Dihydroindole and tetrahydroquinoline derivatives
03/10/2004CN1481364A Urea and urethane derivatives as integrin inhibitors
03/10/2004CN1481250A Improved and stable extract from hypericum perforatuml, method for prodn thereof
03/10/2004CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same
03/10/2004CN1480216A Compound antimicrobial for treating wound of body surface and its preparing method
03/10/2004CN1480210A Usage of leptin for promoting healing of wound
03/10/2004CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity
03/10/2004CN1480199A Powder for sterilizing bacterium, climinating sore, removing purulence and promoting tissue regeneration as well as its preparing method
03/10/2004CN1480198A Medicine for treating scald and burn as well as its preparing method
03/10/2004CN1480188A Ointment for child's allergic dermatitis
03/10/2004CN1480187A Medication for treating impetigo
03/10/2004CN1480169A Ointment for treating beriberi and its preparing method
03/10/2004CN1480162A Medication for treating burn and its preparing method
03/10/2004CN1480154A Application of purified fox oil in paste of external use
03/10/2004CN1480153A Tinea cruris ointment
03/10/2004CN1480143A Formula of preparation for killing acarid and its making method
03/10/2004CN1480139A Local medical compsn contg cholinergic medicine or calcium passage retardant
03/10/2004CN1480133A Externally-used preparation for preventing and curing skin decrepitude and possessing effect of health and beautification
03/10/2004CN1480128A Preparation of transparent, cryptomorphic external remedy
03/10/2004CN1141298C Carbostyril derivs. for inhibiting skin erythema and/or skin pigmentation
03/10/2004CN1141132C Externally applied ointment for treating burns, wound and frost bite and its prepn method
03/10/2004CN1141128C Compound oyster shell liquid
03/10/2004CN1141124C Chinese Medicine prepn for treating leukoderma and its prepn method
03/10/2004CN1141117C Wine for treating injury
03/10/2004CN1141112C Chinese-medicinal ointment for treating burn and scald
03/10/2004CN1141096C Use of 1-hydroxy-2-pyridones for treatment of skin diseases
03/10/2004CN1141095C Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethy1)-anilid and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide
03/10/2004CN1141082C Skin-care honey juice for elimianting comedo on face
03/10/2004CN1141080C Skin-care products
03/09/2004US6703490 Amphiphilic complexes, method for their preparation and compositions containing them
03/09/2004US6703444 Contacting with crosslinking agents so as to form two or more chemically distinct crosslinks between hyaluronic acid and the polymer; products with medical applications
03/09/2004US6703423 For therapy of polymorphoneutrophil (pmn) inflammation
03/09/2004US6703404 Nitric oxide synthase inhibitors
03/09/2004US6703387 Inhibitors of HPV E1 helicase enzyme
03/09/2004US6703052 Long chain monounsaturated alcohol mixtures
03/09/2004US6703049 Angiogenesis inhibitor
03/09/2004CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors
03/09/2004CA2052229C Antifungal composition in a dry powdered spray form
03/05/2004CA2437690A1 Ganoderma lucidum spores for treatment of autoimmune diseases
03/04/2004WO2004018465A2 Benzonaphthyridines with pde 3/4 inhibiting activity
03/04/2004WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
03/04/2004WO2004018451A1 Pyridazinone-derivatives as pde4 inhibitors
03/04/2004WO2004018434A1 Pyrimidine compounds
03/04/2004WO2004018431A2 Novel phenanthridines
03/04/2004WO2004018430A1 COMPOUND HAVING TGFß INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
03/04/2004WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators
03/04/2004WO2004018421A1 Idol derivatives as new thyroid receptor agonist ligands and methods
03/04/2004WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
03/04/2004WO2004018042A2 Use of antisense oligonucleotides for treating degenerative skin symptoms
03/04/2004WO2004017995A1 Preventive and/or therapeutic drugs for itch
03/04/2004WO2004017980A1 Whitening agent
03/04/2004WO2004017966A1 Five-membered heterocyclic compounds in the treatment of chronic and acute pain
03/04/2004WO2004017965A1 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
03/04/2004WO2004017962A2 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region
03/04/2004WO2004017948A2 Use of lck inhibitor for treatment of immunologic diseases
03/04/2004WO2003106456A3 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity
03/04/2004WO2003076604A3 Surgical device for skin therapy or testing
03/04/2004WO2003070755A3 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier
03/04/2004WO2003060082A3 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
03/04/2004WO2003059276A3 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
03/04/2004WO2003051365A3 Use of compounds of the benzamide family as immunosuppressant
03/04/2004WO2003050067A3 Vitamin d analogues
03/04/2004WO2003015789A3 A pharmaceutical composition for dermal application
03/04/2004WO2003015759A3 Treatment of hyperproliferative conditions of body surfaces
03/04/2004WO2002096867A3 Inhibitors of protein kinase for the treatment of disease
03/04/2004WO2002092762A3 Cytokine polypeptides
03/04/2004WO2002066000A3 Novel cosmetic slimming compositions containing boldine
03/04/2004WO2002022134A8 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
03/04/2004US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate
03/04/2004US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors
03/04/2004US20040044194 Aggrecanase molecules
03/04/2004US20040044077 Agents for inhibiting or restoring skin damage caused by drying and method for evaluating the same
03/04/2004US20040044057 5- substituted tetralones as inhibitors of ras farnesyl trransferase
03/04/2004US20040044051 Cannabinoid receptor agonists
03/04/2004US20040044050 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents
03/04/2004US20040044044 Thiazolyl urea compounds and methods of uses
03/04/2004US20040044038 Polymorphic form XVI of fexofenadine hydrochloride
03/04/2004US20040044036 Piperidine derivatives and drugs containing these derivatives as active ingredient
03/04/2004US20040044026 3-Substituted quinuclidines and their use as nicotinic agonists
03/04/2004US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor
03/04/2004US20040044013 Antiarthritic agents; side effect reduction
03/04/2004US20040044010 Central nervous system disorders; Alzheimer's disease; Parkinson's disease
03/04/2004US20040044003 Therapeutic agents useful for treating pain
03/04/2004US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents